Meanwhile, mRNA vaccine maker Moderna is cutting around 500 jobs (10% of its workforce) as part of a commitment to save $1.5 ...

Merck & Co., Inc. has kicked off two Phase 3 trials for its experimental PrEP therapy, MK-8527. **The trials, EXPrESSIVE-10 ...

US PHARMACEUTICAL giant Merck & Co plans to cut around 6,000 jobs, mirroring similar cost-saving measures among rival drug ...

Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer recently talked about. Cramer mentioned the stock and said that ...

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

Merck's Phase 3 trial shows Keytruda plus Padcev improves survival in muscle-invasive bladder cancer patients ineligible for ...

Merck & Co., Inc. (NYSE: MRK) is one of the best depressed stocks to buy in 2025. On August 2, the company completed the ...

Merck (MRK) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Impax Asset Management, an investment management company, released its “Impax US Sustainable Economy Fund” second-quarter ...

RAHWAY, N.J. - Merck & Co., Inc. (NYSE:MRK), also known as MSD outside the United States and Canada, has revealed positive safety and efficacy results from the Phase 1 KANDLELIT-001 study, which ...

Merck’s Q1 2025 performance showed divergent results across its business segments. While overall sales declined, the company highlighted that excluding GARDASIL sales in China, which dropped ...